Agenda — BioLife Summits

Join us for coffee, tea, and breakfast before panels begin! Fuel up for a day full of networking, discussion, and thought-provoking discussion.

BioLife Summits thanks you for spending the day with us and for your incredible support in driving the biotech industry in Chicago!

Before biotech companies can even begin to think about taking a new drug candidate to human clinical trials, many regulatory boxes need to be checked. These panelists discuss the importance of discovery and preclinical research phases in drug development, and how to optimize this part of the process. How can technology such as AI streamline the drug discovery process, and what happens once you’ve found a drug candidate?

Moderator:
Jennifer Chadwick, Chief Business Officer, Saros Therapeutics
Panelists:
Daniel Wang, Founding Scientist, CTRL Therapeutics
Donald Davidson, CEO & Co-founder, Creative BioTherapeutics
Kaylin McMahon, VP Operations & Co-founder, Zylem Biosciences
Peter Anastasiou, CEO, Capsida Biotherapeutics

Seamless transition from a preclinical to a clinical stage of drug development is key to success for early biotechs. This panel discusses the strategies for ensuring diversity among trial participants, selecting the most fitting trial design, creation of a comprehensive clinical trial protocol, the vendor and venue selection process, and more.

Moderator:
Michael Gold, Chief Research and Development Officer, Compass Pathways
Panelists:
Sheetal Patel, SVP Clinical Development, Immunovant
Courtney Wells, SVP Clinical Development Operations, Satellos Bioscience
David Sequeira, VP Clinical Development, Azurity Pharmaceuticals
Shyam Khatau, VP Life Sciences, Tempus

Refresh with drinks, snacks, and dedicated time for networking with your fellow attendees.

This panel explores the paths to getting a new drug, product, or technology to market with the least amount of resistance. Experts discuss the outlook of today’s market, working with the FDA, distribution channels, and various other barriers to navigate. From seeking FDA approval to growing a global brand - vision and strategy matter.

Moderator:
Cassie Jung, COO, Aquestive Therapeutics
Panelists:
Daniel Gallo, EVP Clinical Development & Medical Affairs, Jaguar Gene Therapy
Peter Sullivan, VP Market Access & Strategic Partnerships, Cormedix
Subhadip Jana, Senior Director, Global Regulatory Affairs, ADC Therapeutics

Today’s technology allows for the rise of innovation, leading to the development of highly impactful medical devices and diagnostic tools that can be used to both identify and combat an array of health problems. Panelists discuss the challenges they’ve faced and how to overcome them, as well as navigating the regulatory processes.

Moderator:
Honey Reddi, SVP and Medical Director, Belay Diagnostics
Panelists:
David Peritt, CSO & Founder, Lupagen
Craig Davis, CEO, NovaScan
Shetha Shukair, Director Clinical & Translational Research, Briteseed
David Johnston, Chief Product Officer & Co-founder, Torramics

BioLife Summits provided lunch alongside great conversation with your fellow attendees.

These healthcare companies are making a huge impact on their communities. Listen to panelists discuss how they’re handling the up’s and down’s of today’s market, what resources they’re leveraging to find success, and more.

Moderator:
Joel Matos, VP & Co-founder, TalentCraft Life Sciences
Panelists:
George Pappas, CEO, Delphian Therapeutics
Meesha Dogan, CEO & Co-founder, Cardio Diagnostics
Kevin Honaker, CEO, BiomeSense
Tim Foley, Chief Business Officer, Scailyte

Refresh with drinks, snacks, and dedicated time for networking with your fellow attendees.

This panel brings together experts in business development to discuss how companies can set themselves, and possible investors, up for success in the dynamic investment landscape. Panelists discuss the unique challenges and advantages of private and public financing, developing M&A strategies, assessing the capital investment trends, and more.

Moderator:
Gianina Varea, Senior Director, Venture Development, Portal Innovations
Panelists:
Modestus Obochi, Chief Business Officer, Sernova
Anna Lisa Somera, CEO, Rhaeos
Andrew Serafin, Chief Strategy Officer, Harmony Bioscience
Nick Manusos, CEO, Kenai Therapeutics

As pioneers in research, leadership, and entrepreneurship, this incredible group of women are driving innovation and shaping the future of biotechnology. These panelists will share their insights on overcoming challenges, fostering inclusive environments, and championing groundbreaking advancements.

Moderator:
Deanna Stallsmith, Senior VP, Creative, Pivot Design
Panelists:
Honey Reddi, SVP and Medical Director, Belay Diagnostics
Amanda Schalk, COO & Co-founder, Enzyme by Design
Jane Kiernan, CEO, Surgimatix
Azurii Collier, Director, Strategy & Innovation, AbbVie
Hoyee Leong, VP Medical Affairs, Apnimed

Cocktail Networking Hour